MediWales
News & Opportunity
…over £4.8 million per annum over five years for NHS hospitals across the UK[1]. To learn more about our Forceps, click here. Clearway Suction Handles Innovatively engineered to maximise patient comfort, making it particularly suitable for you to use in A&E/ER practice. Our Suction Handle reduces the need for surgical intervention that uses expensive theatre time, whilst cutting the “four-hour” standard waiting time in A&E[2] by treating patients i…
News & Opportunity
…klog – we cannot go on with business as usual. We are going to harness the latest technology and innovative new ways of working such as surgical hubs to deliver the millions more appointments, treatments and surgeries that are needed over the coming months and years to tackle waiting lists. Professor Steve Powis, NHS England medical director, said: Although the pandemic is still with us and we will have to live with the impact of COVID for some ti…
News & Opportunity
…funding has been made possible by a partnership between Health and Care Research Wales, Cancer Research UK, and the Little Princess Trust specifically for children’s cancers. Cardiff is part of a network of 17 ECMCs across the UK, funded by Cancer Research UK, which deliver clinical trials of promising new treatments. Since 2007, when the network was first established, around 30,000 patients have taken part in 2,100 trials. The funding will allow…
News & Opportunity
…in their successful implementation of a quantitative Faecal Immunochemical Test, FIT test, and the associated clinical pathways. This Symptomatic FIT test helps to identify patients who may have significant colorectal disease who will benefit from an urgent referral, thus identifying priority cases while also saving resources and minimising waiting times. Sponsored by the Life Sciences Hub Wales. Start-Up Award, IQ Endoscopes: IQ Endoscopes is dev…
News & Opportunity
…and the aim of having treatment. They list side-effects by likelihood and common frequency and include a free text section for clinicians to document specific side effects for an individual patient. The documents have been created following demand from cancer doctors to help address variation in consent materials between cancer centres and strengthen the shared decision-making process between oncologists and patients. An oncology community survey…
News & Opportunity
…ing up pace. We are developing the mechanical properties of the bioink and testing the biocompatibility and safety profile for use in facial reconstruction. “Alongside the tissue engineering and 3D bioprinting research, we are critically analysing the patient pathways in skin cancer management, and with the huge personal, health economic and environmental costs in mind – using cutting edge technologies such as natural language processing and artif…
News & Opportunity
…pp and to register. When someone has a cardiac arrest, they collapse and become unresponsive. They either stop breathing entirely, or they may take gasping or infrequent breaths for a few minutes, which can be misinterpreted as snoring. If you see someone having a cardiac arrest, phone 999 immediately and start CPR. In addition, a defibrillator will deliver a controlled electric shock to try and get the heart beating normally again. Ambulance call…
News & Opportunity
…e an anti-malaria drug championed by former US President Donald Trump. “It [the study] has also helped show what treatments don’t work, including the malaria drug hydroxychloroquine,” said Mr Gething. “All health boards with intensive care units are recruiting to a trial led by Imperial College London, which is aiming to identify treatments for people requiring intensive care. About 250 patients have taken part in this study. It has shown two rheu…
Member
News & Opportunity
…me’. Today the government announced that Sterling Pharma Solutions are the latest recipient of funding through the Life Sciences Innovative Manufacturing Fund. This announcement follows the first tranche of four grants from the Life Sciences Innovative Manufacturing Fund in March 2023 and the Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF). Health and Social Care Secretary Steve Barclay said: “This investment is another signifi…